Series C funding round for Oculis raising $57M in May 2021
Series C funding round for Oculis raising $57M in May 2021
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Kiersten Stead |
| Angel | Farzad Nazem |
| Angel | Zhi Yang |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$297M
Top Valuation
-
Oculis raised $57M in a Series C round.
The round was announced on 05/01/21.
The round was led by BVCF (Bioveda China Fund), Dr. Sylvia Xin He.